19th IDS Congress
Paris 2023

23-27 May. 2023

The Immunology of Diabetes Society (IDS) is a scientific society dedicated to improving understanding and treatment of type 1 diabetes. IDS organizes a Congress every 18 months in major centres in Europe, North America and Asia/Oceania at which there are scientific presentations to further this goal.

Centre international de Conférences Sorbonne Université

4 place Jussieu - 44-55

75005 - Paris, France

logo ids_edited.jpg
*To submit before 15th February 2023

Confirmed Speakers

(by alphabetical order)

Peter Achenbach, Mark Atkinson, Jean-François Bach, Burkhard Becher, Polly Bingley, Christian Boitard, Ezio Enrico Bonifacio, Marcela Brissova, Todd Brusko, Jenny Couper, Mark M. Davis, Gerard Eberl, Decio L. Eizirik, Donna Farber, Jean-François Gautier, Carla Greenbaum, John Harris, Len Harrisson, Matthias Hebrok, Kevan Herold, Heikki Hyoty, Sally Kent, David Klatzmann, Aaron J. Kowalski, Jeffrey Krischer, Vito Lampasona, Peter E. Lipsky, Chantal Mathieu, Eoin McKinney, Gerald T. Nepom, Maria Cristina Nostro, Timo Otonkoski, Alberto Pugliese, Frédéric Rieux-Laucat, Bart Roep, Miguel Sanjuan, Pere Santamaria, Andrea Schietinger, Anath Shalev, Tommi Suvitaival, Qizhi Tang, Timothy Tree, Tommi Vatanen, Carola Vinuesa, John Wentworth, Benjamin Youngblood, Anette Ziegler


 Friday 26th

8.20 am

Plenary 4

Circulating vs tissue immune cells: Donna Farber (Columbia University, New York)

9.00 am

11.00 am

Short Symposium 6: Theme to be defined

Talk 23 

Talk 24

Oral Abstract 20

Oral Abstract 21

Oral Abstract 22

Short Symposium 5: Blood omics

Talk 21: Sense and non-sense of multi-omics screening strategies in T1D: Tim Tree (King’s College, London)

Talk 22: CyTOF/RNAseq biomarkers in TrialNet/TEDDY at-risk subjects: Eoin McKinney (University of Cambridge)

Oral Abstract 17

Oral Abstract 18

Oral Abstract 19

12.30 am

Antibody Workshop session – Chairs: Peter Achenbach, Vito Lampasona

1.30 - 2.30 pm

10.30 - 11 am

2.30 pm

5.00 pm 

Long Symposium 5: Trials with new results

Talk 25: Coxsackievirus vaccination trial: Miguel Sanjuan (Provention)

Talk 26: Baricitinib in new-onset T1D: John Wentworth (University of Melbourne)

Talk 27: ActoBio Lactococcus lactis / Teplizumab: Chantal Mathieu (UZ Leuven)

Talk 28: Teplizumab update & biomarkers in TN10 prevention trial: Kevan Herold (Yale University, New Haven)

Talk 29: Low-dose IL-2, DIAB-IL2 trial: David Klatzmann (Sorbonne University, Paris)

Talk 30: Wrap-up: how good is good enough? Challenges and realities of T1D prevention/intervention: Anette Ziegler (Helmholtz, Munich)

Debate 2: type 1 diabetes endotypes: age and beyond

It all comes to age: Ezio Bonifacio (TUD, Dresden)

It is much more than age: Carla Greenbaum (Benaroya Research Institute, Seattle)

6.00 pm 

6.30 pm

Poster Blast 3 (31 to 45)


90” and 1 plain slide/each

Poster Session 3 (31 to 45)


90” and 1 plain slide/each

4.30 - 5.00 pm

7.45 pm

Dinner on your own